News
Amended Biodiversity laws are more biotech friendly now say ABLE experts
Dr Malathi and Mr Ravi highlighted the 8 key amendments that will ease the way for doing biotech business in the country using natural resources.
ABLE member Serum Institute multivalent meningococcal meningitis vaccine gets WHO prequalification
MenFive®, the first conjugate vaccine to protect against the five predominant causes of meningococcal meningitis in Africa, has been prequalified by the World Health Organization (WHO)
ABLE member Bugworks gets big funding for antibiotic development
Bengaluru-based startup Bugworks will receive funding and other support from the Global Antibiotic Research & Development Partnership (GARDP), a non-profit co-founded by the WHO, to develop a new antibiotic to treat drug-resistant bacterial infection.
